data_1xna_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1xna _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ptt? . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -86.45 53.71 3.06 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 123.468 2.778 . . . . 0.0 110.421 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -139.4 177.11 8.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.619 -0.676 . . . . 2.3799999999999999 109.534 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.412 HG22 HD11 ' A' ' 4' ' ' ILE . 93.2 mt -139.75 128.18 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.96 -0.756 . . . . 1.25 108.96 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -117.43 160.03 21.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.644 -0.66 . . . . 3.8300000000000001 109.594 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.2 mp -91.06 159.04 16.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.655 -0.653 . . . . 2.0499999999999998 109.72 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -115.35 -52.82 2.65 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.145 -0.687 . . . . 3.0800000000000001 109.145 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -160.64 163.0 32.89 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.457 -0.572 . . . . 0.46999999999999997 109.457 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.88 90.07 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.523 -0.735 . . . . 1.1200000000000001 109.16 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.6 p -52.51 -60.54 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.182 -0.949 . . . . 1.1000000000000001 110.248 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.418 ' CB ' ' HB ' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -121.1 156.68 31.74 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.5 -0.926 . . . . 1.3100000000000001 108.5 -179.84 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.3 p -151.5 141.66 22.25 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.242 -0.911 . . . . 0.92000000000000004 110.85 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -137.0 47.31 2.14 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.385 -0.598 . . . . 1.23 109.385 179.375 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.9 m 153.86 90.04 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 109.17 -0.678 . . . . 1.96 109.17 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.403 ' O ' ' NE2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -157.98 144.37 17.55 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.139 -0.976 . . . . 3.1200000000000001 109.474 179.486 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.85 -168.31 1.86 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.258 -0.901 . . . . 1.26 109.779 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.47 -66.67 0.89 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.658 -0.651 . . . . 1.54 109.356 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.51 -60.58 3.17 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.802 -0.814 . . . . 1.4399999999999999 108.802 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -90.19 71.1 7.26 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.559 -0.904 . . . . 1.6499999999999999 108.559 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.8 p -89.46 168.57 12.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.526 -0.734 . . . . 0.97999999999999998 109.782 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.417 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -64.15 -23.23 67.24 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.814 -0.554 . . . . 1.0800000000000001 109.515 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -63.03 -17.77 62.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.324 -0.86 . . . . 1.23 109.719 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -64.53 -18.58 64.96 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.175 -0.953 . . . . 0.72999999999999998 109.27 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.9 mt -65.08 -27.4 68.74 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.572 -0.899 . . . . 1.04 108.572 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.19 -21.3 61.56 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 121.526 -0.733 . . . . 1.1699999999999999 109.058 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -114.99 65.33 0.68 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.56 -0.904 . . . . 3.1400000000000001 108.56 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.62 -24.73 8.93 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.374 -0.829 . . . . 1.22 110.44 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -120.71 83.01 2.0 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.409 -0.807 . . . . 2.2599999999999998 109.778 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -155.53 -87.95 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.497 -0.752 . . . . 1.8500000000000001 109.398 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -178.04 35.06 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.186 -0.946 . . . . 1.6799999999999999 109.96 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -159.96 144.25 14.62 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 3.3700000000000001 109.275 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 0.2 OUTLIER -127.33 -164.08 1.32 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.478 -0.764 . . . . 2.5099999999999998 109.368 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.458 ' CH2' ' CD1' ' A' ' 43' ' ' ILE . 20.0 t90 -87.1 140.24 29.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.438 -0.789 . . . . 0.34999999999999998 109.263 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -145.19 126.81 15.15 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.078 -1.082 . . . . 2.9199999999999999 108.078 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.71 147.92 4.4 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.559 -0.713 . . . . 1.04 110.508 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.59 -23.02 24.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.776 -0.578 . . . . 1.1499999999999999 110.368 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -141.57 -174.93 4.18 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.805 -0.813 . . . . 3.6099999999999999 108.805 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.22 -165.64 1.4 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.382 -0.599 . . . . 1.21 109.382 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 65.9 45.6 87.1 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 108.585 -1.806 . . . . 1.3300000000000001 108.585 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.452 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -52.12 88.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.468 0.651 . . . . 2.6099999999999999 111.153 -179.436 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 39' ' ' GLY . 27.0 ttmt -96.28 -49.57 5.15 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.154 -1.054 . . . . 3.0299999999999998 108.154 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.8 p -160.09 121.68 3.18 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.185 -1.043 . . . . 1.05 108.185 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.458 ' CD1' ' CH2' ' A' ' 33' ' ' TRP . 10.1 pt -123.34 143.89 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.465 -0.772 . . . . 1.1200000000000001 109.856 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 0.5 OUTLIER -122.35 148.23 45.31 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.578 -0.849 . . . . 1.1599999999999999 109.243 178.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.6 p -154.79 105.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 109.048 -0.723 . . . . 1.0900000000000001 109.048 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.418 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 6.3 t -90.25 118.77 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.817 -0.808 . . . . 1.1399999999999999 108.817 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.03 151.63 23.73 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.424 -0.584 . . . . 1.21 109.424 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -93.67 161.88 14.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.701 -0.624 . . . . 1.76 109.49 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.6 mt -111.04 125.51 53.82 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.161 -1.051 . . . . 2.0699999999999998 108.161 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -51.35 -9.96 0.08 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.295 -0.878 . . . . 2.0099999999999998 112.17 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -162.15 139.23 8.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.805 -1.184 . . . . 1.6100000000000001 109.077 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -74.72 113.53 12.1 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.473 -0.767 . . . . 1.3500000000000001 109.018 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.2 177.97 8.59 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.809 -0.811 . . . . 2.3199999999999998 108.809 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -84.86 -173.89 4.97 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.565 -0.902 . . . . 0.55000000000000004 108.565 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mp -139.41 120.64 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.443 -0.785 . . . . 1.1499999999999999 109.459 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -111.51 -28.75 8.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.685 -0.635 . . . . 1.72 109.344 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.433 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 2.8 m -149.5 146.39 27.37 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.382 -0.969 . . . . 0.81000000000000005 108.382 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.427 HG11 ' CD1' ' A' ' 149' ' ' PHE . 64.5 t -130.13 163.15 36.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.743 -0.598 . . . . 1.1100000000000001 109.388 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -140.95 127.83 20.51 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.557 -0.714 . . . . 1.6499999999999999 109.51 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -146.89 133.81 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 107.653 -1.24 . . . . 1.22 107.653 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -102.82 135.54 12.35 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.133 -1.587 . . . . 0.47999999999999998 109.133 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -84.91 126.58 33.61 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 122.143 -0.622 . . . . 3.04 110.476 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -113.31 77.29 1.04 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.506 -1.294 . . . . 1.3300000000000001 107.506 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.87 17.42 80.15 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.845 -1.702 . . . . 0.77000000000000002 108.845 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 p -95.54 177.31 5.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.456 -1.026 . . . . 1.79 109.441 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.29 -51.61 0.53 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.239 -0.652 . . . . 1.0800000000000001 109.239 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -109.02 131.26 55.24 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 120.037 -0.665 . . . . 0.47999999999999998 109.77 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.3 t -132.28 112.71 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.571 -0.706 . . . . 1.1000000000000001 109.943 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -105.68 148.71 27.1 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.336 -0.616 . . . . 1.3500000000000001 109.336 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.4 t -137.5 126.19 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.585 -0.697 . . . . 1.1399999999999999 109.702 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 mp -111.54 160.32 17.28 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 107.975 -1.12 . . . . 1.1599999999999999 107.975 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.4 m -120.52 159.26 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.676 -0.64 . . . . 1.1699999999999999 110.377 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.75 170.68 41.08 Favored Glycine 0 N--CA 1.483 1.8 0 N-CA-C 109.435 -1.466 . . . . 0.40000000000000002 109.435 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.8 t -115.61 163.34 15.93 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.799 0.809 . . . . 0.72999999999999998 109.934 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 88.0 p -72.0 -6.32 41.34 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.947 -0.569 . . . . 1.6299999999999999 109.675 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.66 136.49 39.15 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.215 -0.928 . . . . 1.45 110.45 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 64.46 -91.05 0.1 OUTLIER Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.51 -1.436 . . . . 2.3700000000000001 109.51 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.21 54.09 3.11 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.381 -1.487 . . . . 3.0800000000000001 109.381 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.01 -52.3 5.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.577 -0.955 . . . . 3.9500000000000002 109.489 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -135.27 177.54 19.3 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.616 -1.394 . . . . 2.3999999999999999 109.616 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -96.52 24.61 5.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.628 -0.925 . . . . 3.3700000000000001 109.63 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -115.93 10.61 15.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.489 -0.757 . . . . 4.6200000000000001 110.168 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -97.05 34.16 1.79 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.183 -0.948 . . . . 2.2599999999999998 109.561 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -111.71 177.05 4.78 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.203 -1.036 . . . . 0.88 108.203 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.52 134.75 47.94 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.524 -0.917 . . . . 3.0499999999999998 108.524 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.1 t -58.65 89.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-O 121.248 0.547 . . . . 1.1200000000000001 111.138 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.405 ' HA ' HG11 ' A' ' 117' ' ' VAL . 16.9 tp -61.74 -53.93 49.35 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.074 -1.084 . . . . 1.1100000000000001 108.074 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 pp -141.22 118.58 11.45 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 120.089 -0.644 . . . . 1.4099999999999999 109.266 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.1 m -53.03 179.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.535 -0.728 . . . . 1.8100000000000001 110.391 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.13 134.04 52.9 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.11 -0.7 . . . . 1.0700000000000001 109.11 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 6.1 p -104.17 127.54 51.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.317 -0.623 . . . . 1.01 109.317 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 90.6 p -87.54 114.23 23.96 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.408 -0.59 . . . . 1.0800000000000001 109.408 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 91' ' ' SER . 29.2 m-85 -111.53 -47.44 3.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.52 -0.737 . . . . 3.21 109.799 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 5.0 mtp -120.24 -171.13 2.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.685 -0.634 . . . . 1.3999999999999999 109.772 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.0 p -128.05 -179.99 1.11 Allowed Pre-proline 0 N--CA 1.489 1.522 0 N-CA-C 108.221 -1.029 . . . . 1.26 108.221 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -86.27 14.55 2.42 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.997 2.465 . . . . 0.91000000000000003 111.165 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.1 m -120.18 -51.73 2.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.222 -0.924 . . . . 2.0299999999999998 109.666 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -65.27 -24.49 67.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.455 -0.778 . . . . 2.48 110.009 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 85.7 p -60.33 -24.34 64.94 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.35 -0.844 . . . . 1.98 109.939 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -82.36 -82.28 0.14 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.429 -0.795 . . . . 3.2999999999999998 109.832 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.5 t -161.66 38.83 0.13 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.265 -0.897 . . . . 2.1899999999999999 109.278 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -109.97 -30.45 3.44 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.144 -1.582 . . . . 1.47 109.144 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.98 -154.17 0.53 Allowed 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.636 -1.246 . . . . 2.1400000000000001 107.636 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -54.27 109.48 1.57 Allowed Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.308 -0.87 . . . . 1.74 109.984 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -81.04 -10.81 12.5 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.69 2.26 . . . . 0.96999999999999997 110.093 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.75 132.02 9.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.75 -0.594 . . . . 1.21 109.64 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.8 mtp85 -151.53 149.7 29.51 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.764 -0.828 . . . . 3.1200000000000001 108.764 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.526 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 10.6 m -114.38 139.43 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.44 -0.787 . . . . 2.0699999999999998 110.045 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.92 173.84 10.77 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.551 -0.718 . . . . 3.0800000000000001 109.106 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.8 mtm -142.31 177.11 8.48 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.514 0.673 . . . . 2.21 109.972 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 2.2 m-85 -136.59 158.86 43.46 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.248 -1.019 . . . . 0.57999999999999996 108.248 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -128.44 -149.25 6.93 Favored Glycine 0 N--CA 1.484 1.866 0 N-CA-C 109.014 -1.634 . . . . 0.51000000000000001 109.014 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.431 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.3 Cg_endo -74.69 -39.1 1.48 Allowed 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 123.63 2.887 . . . . 0.60999999999999999 110.791 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -65.47 -29.97 70.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.476 -0.765 . . . . 1.99 109.51 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -87.21 3.26 47.23 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 120.1 -0.64 . . . . 2.7000000000000002 110.564 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.432 ' CD1' ' CB ' ' A' ' 121' ' ' ALA . 2.0 pp -125.8 139.84 53.17 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.005 -1.059 . . . . 1.71 110.018 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.44 HG12 ' CB ' ' A' ' 120' ' ' ALA . 9.0 p -61.18 131.41 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.819 -0.808 . . . . 1.1299999999999999 108.819 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -72.83 -39.4 66.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.332 -0.855 . . . . 3.3999999999999999 109.485 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.78 -24.34 61.62 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.567 -0.708 . . . . 1.1799999999999999 110.57 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.44 ' CB ' HG12 ' A' ' 117' ' ' VAL . . . -112.89 -47.65 3.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.344 -0.847 . . . . 1.1200000000000001 110.246 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.432 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -49.05 -37.33 20.59 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.105 -0.997 . . . . 1.21 111.537 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.57 0.0 31.72 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.304 -0.872 . . . . 1.77 110.522 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.437 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 16.9 mttt -93.37 135.72 34.33 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.16 -1.052 . . . . 1.8100000000000001 108.16 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -67.42 112.32 4.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.507 -0.745 . . . . 2.9900000000000002 110.736 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.437 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 81.6 m95 -116.02 163.06 16.47 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.162 -1.051 . . . . 0.47999999999999998 108.162 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -139.57 17.04 2.54 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.389 -0.819 . . . . 1.55 109.734 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -144.37 145.28 31.86 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.227 -1.397 . . . . 2.4399999999999999 107.227 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.35 141.79 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.451 -0.9 . . . . 1.0700000000000001 109.906 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 6.5 tttt -110.44 109.75 20.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.766 -0.584 . . . . 1.8600000000000001 109.613 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 50.1 mm -100.73 120.53 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.353 -0.61 . . . . 1.0800000000000001 109.353 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 40.1 t -126.2 114.59 39.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 O-C-N 121.225 -0.922 . . . . 1.0800000000000001 109.655 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.409 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 50.7 t -89.38 147.67 23.93 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.622 -0.881 . . . . 1.72 108.622 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.507 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -142.59 133.72 25.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.684 -0.635 . . . . 0.71999999999999997 110.967 -178.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.507 ' HB2' ' O ' ' A' ' 133' ' ' SER . 2.7 tp-100 149.7 128.33 0.0 OUTLIER Pre-proline 0 N--CA 1.515 2.796 0 N-CA-C 108.006 -1.109 . . . . 3.0800000000000001 108.006 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -85.1 95.94 0.65 Allowed 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 123.012 2.474 . . . . 0.90000000000000002 109.286 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.452 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 5.7 p90 -124.67 -14.2 6.83 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.47 -0.768 . . . . 1.1699999999999999 111.793 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.03 -173.54 2.33 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.109 -0.994 . . . . 2.0600000000000001 110.211 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.1 tttm -170.66 -40.47 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.247 -0.649 . . . . 3.4100000000000001 109.247 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -111.0 -40.34 4.52 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.593 0.711 . . . . 1.77 109.47 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.39 145.87 31.41 Favored Pre-proline 0 C--N 1.298 -1.663 0 N-CA-C 109.325 -0.621 . . . . 1.4099999999999999 109.325 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.407 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 43.7 Cg_endo -87.04 163.42 8.73 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 123.21 2.606 . . . . 0.81999999999999995 110.813 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.407 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.5 OUTLIER -167.76 -165.9 0.69 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.206 -1.035 . . . . 3.6699999999999999 108.206 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.93 -108.94 0.38 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.56 -1.305 . . . . 0.5 110.927 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.3 mp -116.31 153.03 32.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.641 -0.917 . . . . 2.1200000000000001 110.759 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.411 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 7.3 m -84.44 -28.11 27.09 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.951 -0.759 . . . . 1.0900000000000001 108.951 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.486 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 44.3 p90 -178.25 165.98 1.88 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.433 -0.792 . . . . 0.46999999999999997 109.045 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.3 m -141.99 137.59 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.892 -0.781 . . . . 1.1399999999999999 108.892 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -144.84 163.9 32.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.706 -0.621 . . . . 2.6299999999999999 109.952 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.427 ' CD1' HG11 ' A' ' 58' ' ' VAL . 57.4 m-85 -142.45 154.61 44.7 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.594 -0.891 . . . . 0.58999999999999997 108.594 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.433 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -155.62 131.53 9.95 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.25 -0.907 . . . . 1.97 109.794 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.052 -0.721 . . . . 1.6000000000000001 109.052 -179.933 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ptt? . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -86.45 53.71 3.06 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 123.468 2.778 . . . . 0.0 110.421 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -139.4 177.11 8.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.619 -0.676 . . . . 2.3799999999999999 109.534 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.448 HD13 ' OE1' ' A' ' 53' ' ' GLU . 93.2 mt -139.75 128.18 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.96 -0.756 . . . . 0.67000000000000004 108.96 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -117.43 160.03 21.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.644 -0.66 . . . . 3.2999999999999998 109.594 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.662 ' CD2' HD22 ' A' ' 47' ' ' LEU . 2.2 mp -91.06 159.04 16.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.655 -0.653 . . . . 1.4399999999999999 109.72 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.59 ' C ' HD11 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -115.35 -52.82 2.65 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.145 -0.687 . . . . 2.4700000000000002 109.145 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -160.64 163.0 32.89 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.457 -0.572 . . . . 0.40999999999999998 109.457 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.64 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.5 p -79.88 90.07 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.523 -0.735 . . . . 0.42999999999999999 109.16 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.545 HG13 ' H ' ' A' ' 11' ' ' SER . 1.6 p -52.51 -60.54 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.182 -0.949 . . . . 0.39000000000000001 110.248 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.545 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -121.1 156.68 31.74 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.5 -0.926 . . . . 0.91000000000000003 108.5 -179.84 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.413 ' HB2' ' HG2' ' A' ' 15' ' ' GLN . 20.3 p -151.5 141.66 22.25 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.242 -0.911 . . . . 0.55000000000000004 110.85 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -137.0 47.31 2.14 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.385 -0.598 . . . . 0.96999999999999997 109.385 179.375 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.666 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.9 m 153.86 90.04 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 109.17 -0.678 . . . . 1.3799999999999999 109.17 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.603 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -157.98 144.37 17.55 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.139 -0.976 . . . . 2.3500000000000001 109.474 179.486 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.85 -168.31 1.86 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.258 -0.901 . . . . 1.26 109.779 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.47 -66.67 0.89 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.658 -0.651 . . . . 1.26 109.356 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.51 -60.58 3.17 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.802 -0.814 . . . . 0.88 108.802 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -90.19 71.1 7.26 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.559 -0.904 . . . . 1.0800000000000001 108.559 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.8 p -89.46 168.57 12.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.526 -0.734 . . . . 0.26000000000000001 109.782 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.828 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -64.15 -23.23 67.24 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.814 -0.554 . . . . 0.26000000000000001 109.515 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -63.03 -17.77 62.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.324 -0.86 . . . . 1.23 109.719 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -64.53 -18.58 64.96 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.175 -0.953 . . . . 0.47999999999999998 109.27 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.828 HD21 ' HB2' ' A' ' 33' ' ' TRP . 9.9 mt -65.08 -27.4 68.74 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.572 -0.899 . . . . 0.29999999999999999 108.572 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.59 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.3 mm? -60.19 -21.3 61.56 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 121.526 -0.733 . . . . 0.5 109.058 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -114.99 65.33 0.68 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.56 -0.904 . . . . 2.6600000000000001 108.56 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.62 -24.73 8.93 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.374 -0.829 . . . . 0.72999999999999998 110.44 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.477 ' O ' HG23 ' A' ' 29' ' ' THR . 2.4 m-20 -120.71 83.01 2.0 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.409 -0.807 . . . . 2.2599999999999998 109.778 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 28' ' ' ASP . 0.8 OUTLIER -155.53 -87.95 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.497 -0.752 . . . . 1.23 109.398 179.612 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -178.04 35.06 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.186 -0.946 . . . . 1.5 109.96 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -159.96 144.25 14.62 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 2.8999999999999999 109.275 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.431 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 0.2 OUTLIER -127.33 -164.08 1.32 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.478 -0.764 . . . . 2.0 109.368 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.828 ' HB2' HD21 ' A' ' 24' ' ' LEU . 20.0 t90 -87.1 140.24 29.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.438 -0.789 . . . . 0.31 109.263 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -145.19 126.81 15.15 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.078 -1.082 . . . . 2.4900000000000002 108.078 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.662 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -50.71 147.92 4.4 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.559 -0.713 . . . . 0.35999999999999999 110.508 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.603 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -55.59 -23.02 24.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.776 -0.578 . . . . 0.48999999999999999 110.368 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -141.57 -174.93 4.18 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.805 -0.813 . . . . 3.2400000000000002 108.805 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.22 -165.64 1.4 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.382 -0.599 . . . . 0.56999999999999995 109.382 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 65.9 45.6 87.1 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 108.585 -1.806 . . . . 1.3300000000000001 108.585 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.452 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -52.12 88.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.468 0.651 . . . . 2.6099999999999999 111.153 -179.436 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.577 ' O ' HG23 ' A' ' 42' ' ' THR . 27.0 ttmt -96.28 -49.57 5.15 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.154 -1.054 . . . . 2.5899999999999999 108.154 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.712 HG22 ' OG ' ' A' ' 133' ' ' SER . 4.8 p -160.09 121.68 3.18 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.185 -1.043 . . . . 0.44 108.185 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.672 HD12 ' CH2' ' A' ' 33' ' ' TRP . 10.1 pt -123.34 143.89 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.465 -0.772 . . . . 0.29999999999999999 109.856 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.676 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.5 OUTLIER -122.35 148.23 45.31 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.578 -0.849 . . . . 1.1000000000000001 109.243 178.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.828 HG21 ' HB1' ' A' ' 21' ' ' ALA . 9.6 p -154.79 105.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 109.048 -0.723 . . . . 0.32000000000000001 109.048 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.596 HG22 ' HG3' ' A' ' 129' ' ' LYS . 6.3 t -90.25 118.77 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.817 -0.808 . . . . 0.34999999999999998 108.817 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.662 HD22 ' CD2' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -105.03 151.63 23.73 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.424 -0.584 . . . . 0.39000000000000001 109.424 -179.09 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -93.67 161.88 14.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.701 -0.624 . . . . 1.76 109.49 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.585 HD12 ' HA ' ' A' ' 126' ' ' ASP . 59.6 mt -111.04 125.51 53.82 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.161 -1.051 . . . . 1.3999999999999999 108.161 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -51.35 -9.96 0.08 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.295 -0.878 . . . . 2.0099999999999998 112.17 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -162.15 139.23 8.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.805 -1.184 . . . . 1.04 109.077 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -74.72 113.53 12.1 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.473 -0.767 . . . . 1.3500000000000001 109.018 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.448 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -146.2 177.97 8.59 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.809 -0.811 . . . . 2.3199999999999998 108.809 -179.792 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -84.86 -173.89 4.97 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.565 -0.902 . . . . 0.55000000000000004 108.565 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mp -139.41 120.64 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.443 -0.785 . . . . 0.52000000000000002 109.459 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -111.51 -28.75 8.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.685 -0.635 . . . . 1.0900000000000001 109.344 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.446 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 2.8 m -149.5 146.39 27.37 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.382 -0.969 . . . . 0.42999999999999999 108.382 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.627 HG13 ' CD1' ' A' ' 149' ' ' PHE . 64.5 t -130.13 163.15 36.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.743 -0.598 . . . . 0.40999999999999998 109.388 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.743 ' C ' HD12 ' A' ' 60' ' ' ILE . 1.4 m-20 -140.95 127.83 20.51 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.557 -0.714 . . . . 1.6499999999999999 109.51 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.743 HD12 ' C ' ' A' ' 59' ' ' ASP . 1.2 mp -146.89 133.81 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 107.653 -1.24 . . . . 0.57999999999999996 107.653 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -102.82 135.54 12.35 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.133 -1.587 . . . . 0.45000000000000001 109.133 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.439 ' ND2' ' CD2' ' A' ' 93' ' ' PHE . 3.5 m120 -84.91 126.58 33.61 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 122.143 -0.622 . . . . 2.25 110.476 -178.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.403 ' HB2' ' N ' ' A' ' 145' ' ' SER . 32.7 t0 -113.31 77.29 1.04 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.506 -1.294 . . . . 1.3300000000000001 107.506 178.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.87 17.42 80.15 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.845 -1.702 . . . . 0.67000000000000004 108.845 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 p -95.54 177.31 5.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.456 -1.026 . . . . 1.3700000000000001 109.441 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.826 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -139.29 -51.61 0.53 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.239 -0.652 . . . . 0.42999999999999999 109.239 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -109.02 131.26 55.24 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 120.037 -0.665 . . . . 0.40999999999999998 109.77 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.571 HG11 HG21 ' A' ' 60' ' ' ILE . 48.3 t -132.28 112.71 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.571 -0.706 . . . . 0.29999999999999999 109.943 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -105.68 148.71 27.1 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.336 -0.616 . . . . 1.3500000000000001 109.336 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.694 HG13 ' CD1' ' A' ' 130' ' ' ILE . 20.4 t -137.5 126.19 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.585 -0.697 . . . . 0.34999999999999998 109.702 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.586 HD11 HG22 ' A' ' 86' ' ' VAL . 1.7 mp -111.54 160.32 17.28 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 107.975 -1.12 . . . . 0.40999999999999998 107.975 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.618 HG13 ' HB2' ' A' ' 87' ' ' LEU . 3.4 m -120.52 159.26 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.676 -0.64 . . . . 0.34999999999999998 110.377 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.75 170.68 41.08 Favored Glycine 0 N--CA 1.483 1.8 0 N-CA-C 109.435 -1.466 . . . . 0.35999999999999999 109.435 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.8 t -115.61 163.34 15.93 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.799 0.809 . . . . 0.37 109.934 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 88.0 p -72.0 -6.32 41.34 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.947 -0.569 . . . . 1.29 109.675 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.66 136.49 39.15 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.215 -0.928 . . . . 1.45 110.45 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 64.46 -91.05 0.1 OUTLIER Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.51 -1.436 . . . . 2.3700000000000001 109.51 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.21 54.09 3.11 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.381 -1.487 . . . . 2.71 109.381 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.01 -52.3 5.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.577 -0.955 . . . . 3.48 109.489 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -135.27 177.54 19.3 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.616 -1.394 . . . . 1.8200000000000001 109.616 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -96.52 24.61 5.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.628 -0.925 . . . . 3.3700000000000001 109.63 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -115.93 10.61 15.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.489 -0.757 . . . . 4.1100000000000003 110.168 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -97.05 34.16 1.79 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.183 -0.948 . . . . 2.2599999999999998 109.561 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -111.71 177.05 4.78 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.203 -1.036 . . . . 0.59999999999999998 108.203 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.444 ' HG3' HG23 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -129.52 134.75 47.94 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.524 -0.917 . . . . 3.0499999999999998 108.524 178.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.586 HG22 HD11 ' A' ' 71' ' ' LEU . 46.1 t -58.65 89.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-O 121.248 0.547 . . . . 0.41999999999999998 111.138 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.618 ' HB2' HG13 ' A' ' 72' ' ' VAL . 16.9 tp -61.74 -53.93 49.35 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.074 -1.084 . . . . 0.40000000000000002 108.074 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.666 HD13 ' CD2' ' A' ' 111' ' ' PHE . 1.4 pp -141.22 118.58 11.45 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 120.089 -0.644 . . . . 0.73999999999999999 109.266 178.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.1 m -53.03 179.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.535 -0.728 . . . . 1.1899999999999999 110.391 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.13 134.04 52.9 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.11 -0.7 . . . . 0.48999999999999999 109.11 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 6.1 p -104.17 127.54 51.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.317 -0.623 . . . . 0.35999999999999999 109.317 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 90.6 p -87.54 114.23 23.96 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.408 -0.59 . . . . 0.75 109.408 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.439 ' CD2' ' ND2' ' A' ' 62' ' ' ASN . 29.2 m-85 -111.53 -47.44 3.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.52 -0.737 . . . . 2.5 109.799 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.652 ' HE3' ' O ' ' A' ' 104' ' ' ASN . 5.0 mtp -120.24 -171.13 2.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.685 -0.634 . . . . 0.76000000000000001 109.772 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.0 p -128.05 -179.99 1.11 Allowed Pre-proline 0 N--CA 1.489 1.522 0 N-CA-C 108.221 -1.029 . . . . 1.0900000000000001 108.221 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -86.27 14.55 2.42 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.997 2.465 . . . . 0.91000000000000003 111.165 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.1 m -120.18 -51.73 2.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.222 -0.924 . . . . 1.78 109.666 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 103' ' ' SER . 3.7 pt-20 -65.27 -24.49 67.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.455 -0.778 . . . . 2.48 110.009 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 85.7 p -60.33 -24.34 64.94 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.35 -0.844 . . . . 1.6200000000000001 109.939 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -82.36 -82.28 0.14 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.429 -0.795 . . . . 2.8199999999999998 109.832 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.5 t -161.66 38.83 0.13 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.265 -0.897 . . . . 1.97 109.278 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -109.97 -30.45 3.44 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.144 -1.582 . . . . 1.3700000000000001 109.144 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 98' ' ' GLU . 0.2 OUTLIER -150.98 -154.17 0.53 Allowed 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.636 -1.246 . . . . 2.1400000000000001 107.636 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.652 ' O ' ' HE3' ' A' ' 94' ' ' MET . 0.3 OUTLIER -54.27 109.48 1.57 Allowed Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.308 -0.87 . . . . 1.52 109.984 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -81.04 -10.81 12.5 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.69 2.26 . . . . 0.84999999999999998 110.093 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.75 132.02 9.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.75 -0.594 . . . . 1.21 109.64 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.8 mtp85 -151.53 149.7 29.51 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.764 -0.828 . . . . 2.52 108.764 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.588 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 10.6 m -114.38 139.43 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.44 -0.787 . . . . 1.4399999999999999 110.045 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.92 173.84 10.77 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.551 -0.718 . . . . 2.6899999999999999 109.106 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.8 mtm -142.31 177.11 8.48 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.514 0.673 . . . . 1.6100000000000001 109.972 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.666 ' CD2' HD13 ' A' ' 88' ' ' LEU . 2.2 m-85 -136.59 158.86 43.46 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.248 -1.019 . . . . 0.57999999999999996 108.248 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -128.44 -149.25 6.93 Favored Glycine 0 N--CA 1.484 1.866 0 N-CA-C 109.014 -1.634 . . . . 0.42999999999999999 109.014 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.536 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.3 Cg_endo -74.69 -39.1 1.48 Allowed 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 123.63 2.887 . . . . 0.59999999999999998 110.791 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -65.47 -29.97 70.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.476 -0.765 . . . . 1.99 109.51 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -87.21 3.26 47.23 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 120.1 -0.64 . . . . 2.2400000000000002 110.564 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.961 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.0 pp -125.8 139.84 53.17 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.005 -1.059 . . . . 1.1000000000000001 110.018 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.921 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 9.0 p -61.18 131.41 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.819 -0.808 . . . . 0.45000000000000001 108.819 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -72.83 -39.4 66.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.332 -0.855 . . . . 2.9100000000000001 109.485 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.78 -24.34 61.62 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.567 -0.708 . . . . 0.76000000000000001 110.57 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.921 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -112.89 -47.65 3.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.344 -0.847 . . . . 0.47999999999999998 110.246 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.961 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -49.05 -37.33 20.59 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.105 -0.997 . . . . 0.54000000000000004 111.537 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.57 0.0 31.72 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.304 -0.872 . . . . 1.77 110.522 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.461 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 16.9 mttt -93.37 135.72 34.33 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.16 -1.052 . . . . 1.27 108.16 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -67.42 112.32 4.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.507 -0.745 . . . . 2.48 110.736 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.461 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 81.6 m95 -116.02 163.06 16.47 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.162 -1.051 . . . . 0.44 108.162 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.585 ' HA ' HD12 ' A' ' 49' ' ' LEU . 2.7 p30 -139.57 17.04 2.54 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.389 -0.819 . . . . 1.55 109.734 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -144.37 145.28 31.86 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.227 -1.397 . . . . 1.97 107.227 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.72 HG11 ' CE2' ' A' ' 149' ' ' PHE . 7.7 p -139.35 141.79 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.451 -0.9 . . . . 0.28999999999999998 109.906 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.596 ' HG3' HG22 ' A' ' 46' ' ' VAL . 6.5 tttt -110.44 109.75 20.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.766 -0.584 . . . . 1.27 109.613 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.694 ' CD1' HG13 ' A' ' 70' ' ' VAL . 50.1 mm -100.73 120.53 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.353 -0.61 . . . . 0.29999999999999999 109.353 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.676 HG22 ' HB3' ' A' ' 44' ' ' SER . 40.1 t -126.2 114.59 39.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 O-C-N 121.225 -0.922 . . . . 0.31 109.655 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.428 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 50.7 t -89.38 147.67 23.93 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.622 -0.881 . . . . 1.1000000000000001 108.622 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.712 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -142.59 133.72 25.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.684 -0.635 . . . . 0.33000000000000002 110.967 -178.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.826 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 0.3 OUTLIER 149.7 128.33 0.0 OUTLIER Pre-proline 0 N--CA 1.515 2.796 0 N-CA-C 108.006 -1.109 . . . . 2.5299999999999998 108.006 178.365 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -85.1 95.94 0.65 Allowed 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 123.012 2.474 . . . . 0.81999999999999995 109.286 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.452 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 5.7 p90 -124.67 -14.2 6.83 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.47 -0.768 . . . . 0.96999999999999997 111.793 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.03 -173.54 2.33 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.109 -0.994 . . . . 1.72 110.211 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.1 tttm -170.66 -40.47 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.247 -0.649 . . . . 3.0099999999999998 109.247 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -111.0 -40.34 4.52 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.593 0.711 . . . . 1.77 109.47 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.5 OUTLIER -103.39 145.87 31.41 Favored Pre-proline 0 C--N 1.298 -1.663 0 N-CA-C 109.325 -0.621 . . . . 0.98999999999999999 109.325 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 43.7 Cg_endo -87.04 163.42 8.73 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 123.21 2.606 . . . . 0.81999999999999995 110.813 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.407 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.5 OUTLIER -167.76 -165.9 0.69 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.206 -1.035 . . . . 3.0499999999999998 108.206 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.93 -108.94 0.38 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.56 -1.305 . . . . 0.40000000000000002 110.927 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.549 HD23 HG23 ' A' ' 60' ' ' ILE . 6.3 mp -116.31 153.03 32.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.641 -0.917 . . . . 1.5600000000000001 110.759 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.431 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 7.3 m -84.44 -28.11 27.09 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.951 -0.759 . . . . 0.88 108.951 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.502 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 44.3 p90 -178.25 165.98 1.88 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.433 -0.792 . . . . 0.40999999999999998 109.045 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.813 HG22 ' HB3' ' A' ' 24' ' ' LEU . 21.3 m -141.99 137.59 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.892 -0.781 . . . . 0.5 108.892 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.422 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 4.9 mtm180 -144.84 163.9 32.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.706 -0.621 . . . . 2.21 109.952 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.72 ' CE2' HG11 ' A' ' 128' ' ' VAL . 57.4 m-85 -142.45 154.61 44.7 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.594 -0.891 . . . . 0.35999999999999999 108.594 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.446 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -155.62 131.53 9.95 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.25 -0.907 . . . . 1.24 109.794 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.052 -0.721 . . . . 1.3899999999999999 109.052 -179.933 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ptt? . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -86.45 53.71 3.06 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 123.468 2.778 . . . . 0.0 110.421 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -139.4 177.11 8.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.619 -0.676 . . . . 2.3799999999999999 109.534 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.448 HD13 ' OE1' ' A' ' 53' ' ' GLU . 93.2 mt -139.75 128.18 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.96 -0.756 . . . . 0.67000000000000004 108.96 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -117.43 160.03 21.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.644 -0.66 . . . . 3.2999999999999998 109.594 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.662 ' CD2' HD22 ' A' ' 47' ' ' LEU . 2.2 mp -91.06 159.04 16.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.655 -0.653 . . . . 1.4399999999999999 109.72 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.59 ' C ' HD11 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -115.35 -52.82 2.65 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.145 -0.687 . . . . 2.4700000000000002 109.145 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -160.64 163.0 32.89 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.457 -0.572 . . . . 0.40999999999999998 109.457 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.64 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.5 p -79.88 90.07 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.523 -0.735 . . . . 0.42999999999999999 109.16 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.545 HG13 ' H ' ' A' ' 11' ' ' SER . 1.6 p -52.51 -60.54 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.182 -0.949 . . . . 0.39000000000000001 110.248 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.545 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -121.1 156.68 31.74 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.5 -0.926 . . . . 0.91000000000000003 108.5 -179.84 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.413 ' HB2' ' HG2' ' A' ' 15' ' ' GLN . 20.3 p -151.5 141.66 22.25 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.242 -0.911 . . . . 0.55000000000000004 110.85 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -137.0 47.31 2.14 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.385 -0.598 . . . . 0.96999999999999997 109.385 179.375 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.666 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.9 m 153.86 90.04 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 109.17 -0.678 . . . . 1.3799999999999999 109.17 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.603 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -157.98 144.37 17.55 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.139 -0.976 . . . . 2.3500000000000001 109.474 179.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.85 -168.31 1.86 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.258 -0.901 . . . . 1.26 109.779 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.47 -66.67 0.89 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.658 -0.651 . . . . 1.26 109.356 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.51 -60.58 3.17 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.802 -0.814 . . . . 0.88 108.802 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -90.19 71.1 7.26 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.559 -0.904 . . . . 1.0800000000000001 108.559 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.8 p -89.46 168.57 12.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.526 -0.734 . . . . 0.26000000000000001 109.782 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.828 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -64.15 -23.23 67.24 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.814 -0.554 . . . . 0.26000000000000001 109.515 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -63.03 -17.77 62.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.324 -0.86 . . . . 1.23 109.719 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -64.53 -18.58 64.96 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.175 -0.953 . . . . 0.47999999999999998 109.27 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.828 HD21 ' HB2' ' A' ' 33' ' ' TRP . 9.9 mt -65.08 -27.4 68.74 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.572 -0.899 . . . . 0.29999999999999999 108.572 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.59 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.3 mm? -60.19 -21.3 61.56 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 121.526 -0.733 . . . . 0.5 109.058 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -114.99 65.33 0.68 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.56 -0.904 . . . . 2.6600000000000001 108.56 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.62 -24.73 8.93 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.374 -0.829 . . . . 0.72999999999999998 110.44 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.477 ' O ' HG23 ' A' ' 29' ' ' THR . 2.4 m-20 -120.71 83.01 2.0 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.409 -0.807 . . . . 2.2599999999999998 109.778 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 28' ' ' ASP . 0.8 OUTLIER -155.53 -87.95 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.497 -0.752 . . . . 1.23 109.398 179.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -178.04 35.06 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.186 -0.946 . . . . 1.5 109.96 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -159.96 144.25 14.62 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 2.8999999999999999 109.275 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.431 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 0.2 OUTLIER -127.33 -164.08 1.32 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.478 -0.764 . . . . 2.0 109.368 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.828 ' HB2' HD21 ' A' ' 24' ' ' LEU . 20.0 t90 -87.1 140.24 29.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.438 -0.789 . . . . 0.31 109.263 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -145.19 126.81 15.15 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.078 -1.082 . . . . 2.4900000000000002 108.078 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.662 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -50.71 147.92 4.4 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.559 -0.713 . . . . 0.35999999999999999 110.508 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.603 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -55.59 -23.02 24.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.776 -0.578 . . . . 0.48999999999999999 110.368 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -141.57 -174.93 4.18 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.805 -0.813 . . . . 3.2400000000000002 108.805 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.22 -165.64 1.4 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.382 -0.599 . . . . 0.56999999999999995 109.382 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 65.9 45.6 87.1 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 108.585 -1.806 . . . . 1.3300000000000001 108.585 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.452 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -52.12 88.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.468 0.651 . . . . 2.6099999999999999 111.153 -179.436 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.577 ' O ' HG23 ' A' ' 42' ' ' THR . 27.0 ttmt -96.28 -49.57 5.15 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.154 -1.054 . . . . 2.5899999999999999 108.154 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.712 HG22 ' OG ' ' A' ' 133' ' ' SER . 4.8 p -160.09 121.68 3.18 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.185 -1.043 . . . . 0.44 108.185 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.672 HD12 ' CH2' ' A' ' 33' ' ' TRP . 10.1 pt -123.34 143.89 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.465 -0.772 . . . . 0.29999999999999999 109.856 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.676 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.5 OUTLIER -122.35 148.23 45.31 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.578 -0.849 . . . . 1.1000000000000001 109.243 178.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.828 HG21 ' HB1' ' A' ' 21' ' ' ALA . 9.6 p -154.79 105.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 109.048 -0.723 . . . . 0.32000000000000001 109.048 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.596 HG22 ' HG3' ' A' ' 129' ' ' LYS . 6.3 t -90.25 118.77 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.817 -0.808 . . . . 0.34999999999999998 108.817 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.662 HD22 ' CD2' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -105.03 151.63 23.73 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.424 -0.584 . . . . 0.39000000000000001 109.424 -179.09 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -93.67 161.88 14.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.701 -0.624 . . . . 1.76 109.49 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.585 HD12 ' HA ' ' A' ' 126' ' ' ASP . 59.6 mt -111.04 125.51 53.82 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.161 -1.051 . . . . 1.3999999999999999 108.161 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -51.35 -9.96 0.08 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.295 -0.878 . . . . 2.0099999999999998 112.17 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -162.15 139.23 8.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.805 -1.184 . . . . 1.04 109.077 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -74.72 113.53 12.1 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.473 -0.767 . . . . 1.3500000000000001 109.018 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.448 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -146.2 177.97 8.59 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.809 -0.811 . . . . 2.3199999999999998 108.809 -179.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -84.86 -173.89 4.97 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.565 -0.902 . . . . 0.55000000000000004 108.565 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mp -139.41 120.64 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.443 -0.785 . . . . 0.52000000000000002 109.459 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -111.51 -28.75 8.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.685 -0.635 . . . . 1.0900000000000001 109.344 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.446 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 2.8 m -149.5 146.39 27.37 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.382 -0.969 . . . . 0.42999999999999999 108.382 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.627 HG13 ' CD1' ' A' ' 149' ' ' PHE . 64.5 t -130.13 163.15 36.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.743 -0.598 . . . . 0.40999999999999998 109.388 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.743 ' C ' HD12 ' A' ' 60' ' ' ILE . 1.4 m-20 -140.95 127.83 20.51 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.557 -0.714 . . . . 1.6499999999999999 109.51 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.743 HD12 ' C ' ' A' ' 59' ' ' ASP . 1.2 mp -146.89 133.81 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 107.653 -1.24 . . . . 0.57999999999999996 107.653 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -102.82 135.54 12.35 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.133 -1.587 . . . . 0.45000000000000001 109.133 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -84.91 126.58 33.61 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 122.143 -0.622 . . . . 2.25 110.476 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.403 ' HB2' ' N ' ' A' ' 145' ' ' SER . 32.7 t0 -113.31 77.29 1.04 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.506 -1.294 . . . . 1.3300000000000001 107.506 178.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.87 17.42 80.15 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.845 -1.702 . . . . 0.67000000000000004 108.845 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 p -95.54 177.31 5.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.456 -1.026 . . . . 1.3700000000000001 109.441 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.826 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -139.29 -51.61 0.53 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.239 -0.652 . . . . 0.42999999999999999 109.239 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -109.02 131.26 55.24 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 120.037 -0.665 . . . . 0.40999999999999998 109.77 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.571 HG11 HG21 ' A' ' 60' ' ' ILE . 48.3 t -132.28 112.71 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.571 -0.706 . . . . 0.29999999999999999 109.943 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -105.68 148.71 27.1 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.336 -0.616 . . . . 1.3500000000000001 109.336 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.694 HG13 ' CD1' ' A' ' 130' ' ' ILE . 20.4 t -137.5 126.19 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.585 -0.697 . . . . 0.34999999999999998 109.702 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.586 HD11 HG22 ' A' ' 86' ' ' VAL . 1.7 mp -111.54 160.32 17.28 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 107.975 -1.12 . . . . 0.40999999999999998 107.975 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.618 HG13 ' HB2' ' A' ' 87' ' ' LEU . 3.4 m -120.52 159.26 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.676 -0.64 . . . . 0.34999999999999998 110.377 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.75 170.68 41.08 Favored Glycine 0 N--CA 1.483 1.8 0 N-CA-C 109.435 -1.466 . . . . 0.35999999999999999 109.435 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.8 t -115.61 163.34 15.93 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.799 0.809 . . . . 0.37 109.934 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 88.0 p -72.0 -6.32 41.34 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.947 -0.569 . . . . 1.29 109.675 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.66 136.49 39.15 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.215 -0.928 . . . . 1.45 110.45 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 64.46 -91.05 0.1 OUTLIER Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.51 -1.436 . . . . 2.3700000000000001 109.51 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.21 54.09 3.11 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.381 -1.487 . . . . 2.71 109.381 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.01 -52.3 5.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.577 -0.955 . . . . 3.48 109.489 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -135.27 177.54 19.3 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.616 -1.394 . . . . 1.8200000000000001 109.616 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -96.52 24.61 5.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.628 -0.925 . . . . 3.3700000000000001 109.63 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -115.93 10.61 15.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.489 -0.757 . . . . 4.1100000000000003 110.168 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -97.05 34.16 1.79 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.183 -0.948 . . . . 2.2599999999999998 109.561 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -111.71 177.05 4.78 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.203 -1.036 . . . . 0.59999999999999998 108.203 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.444 ' HG3' HG23 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -129.52 134.75 47.94 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.524 -0.917 . . . . 3.0499999999999998 108.524 178.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.586 HG22 HD11 ' A' ' 71' ' ' LEU . 46.1 t -58.65 89.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-O 121.248 0.547 . . . . 0.41999999999999998 111.138 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.618 ' HB2' HG13 ' A' ' 72' ' ' VAL . 16.9 tp -61.74 -53.93 49.35 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.074 -1.084 . . . . 0.40000000000000002 108.074 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.666 HD13 ' CD2' ' A' ' 111' ' ' PHE . 1.4 pp -141.22 118.58 11.45 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 120.089 -0.644 . . . . 0.73999999999999999 109.266 178.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.1 m -53.03 179.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.535 -0.728 . . . . 1.1899999999999999 110.391 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.13 134.04 52.9 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.11 -0.7 . . . . 0.48999999999999999 109.11 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 6.1 p -104.17 127.54 51.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.317 -0.623 . . . . 0.35999999999999999 109.317 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 90.6 p -87.54 114.23 23.96 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.408 -0.59 . . . . 0.75 109.408 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 91' ' ' SER . 29.2 m-85 -111.53 -47.44 3.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.52 -0.737 . . . . 2.5 109.799 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.652 ' HE3' ' O ' ' A' ' 104' ' ' ASN . 5.0 mtp -120.24 -171.13 2.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.685 -0.634 . . . . 0.76000000000000001 109.772 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.0 p -128.05 -179.99 1.11 Allowed Pre-proline 0 N--CA 1.489 1.522 0 N-CA-C 108.221 -1.029 . . . . 1.0900000000000001 108.221 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -86.27 14.55 2.42 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.997 2.465 . . . . 0.91000000000000003 111.165 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.1 m -120.18 -51.73 2.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.222 -0.924 . . . . 1.78 109.666 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 103' ' ' SER . 3.7 pt-20 -65.27 -24.49 67.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.455 -0.778 . . . . 2.48 110.009 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 85.7 p -60.33 -24.34 64.94 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.35 -0.844 . . . . 1.6200000000000001 109.939 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -82.36 -82.28 0.14 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.429 -0.795 . . . . 2.8199999999999998 109.832 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.5 t -161.66 38.83 0.13 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.265 -0.897 . . . . 1.97 109.278 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -109.97 -30.45 3.44 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.144 -1.582 . . . . 1.3700000000000001 109.144 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 98' ' ' GLU . 0.2 OUTLIER -150.98 -154.17 0.53 Allowed 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.636 -1.246 . . . . 2.1400000000000001 107.636 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.652 ' O ' ' HE3' ' A' ' 94' ' ' MET . 0.3 OUTLIER -54.27 109.48 1.57 Allowed Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.308 -0.87 . . . . 1.52 109.984 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -81.04 -10.81 12.5 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.69 2.26 . . . . 0.84999999999999998 110.093 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.75 132.02 9.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.75 -0.594 . . . . 1.21 109.64 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.8 mtp85 -151.53 149.7 29.51 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.764 -0.828 . . . . 2.52 108.764 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.588 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 10.6 m -114.38 139.43 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.44 -0.787 . . . . 1.4399999999999999 110.045 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.92 173.84 10.77 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.551 -0.718 . . . . 2.6899999999999999 109.106 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.8 mtm -142.31 177.11 8.48 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.514 0.673 . . . . 1.6100000000000001 109.972 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.666 ' CD2' HD13 ' A' ' 88' ' ' LEU . 2.2 m-85 -136.59 158.86 43.46 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.248 -1.019 . . . . 0.57999999999999996 108.248 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -128.44 -149.25 6.93 Favored Glycine 0 N--CA 1.484 1.866 0 N-CA-C 109.014 -1.634 . . . . 0.42999999999999999 109.014 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.536 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.3 Cg_endo -74.69 -39.1 1.48 Allowed 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 123.63 2.887 . . . . 0.59999999999999998 110.791 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -65.47 -29.97 70.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.476 -0.765 . . . . 1.99 109.51 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -87.21 3.26 47.23 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 120.1 -0.64 . . . . 2.2400000000000002 110.564 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.961 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.0 pp -125.8 139.84 53.17 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.005 -1.059 . . . . 1.1000000000000001 110.018 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.921 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 9.0 p -61.18 131.41 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.819 -0.808 . . . . 0.45000000000000001 108.819 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -72.83 -39.4 66.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.332 -0.855 . . . . 2.9100000000000001 109.485 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.78 -24.34 61.62 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.567 -0.708 . . . . 0.76000000000000001 110.57 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.921 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -112.89 -47.65 3.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.344 -0.847 . . . . 0.47999999999999998 110.246 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.961 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -49.05 -37.33 20.59 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.105 -0.997 . . . . 0.54000000000000004 111.537 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.57 0.0 31.72 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.304 -0.872 . . . . 1.77 110.522 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.461 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 16.9 mttt -93.37 135.72 34.33 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.16 -1.052 . . . . 1.27 108.16 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -67.42 112.32 4.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.507 -0.745 . . . . 2.48 110.736 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.461 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 81.6 m95 -116.02 163.06 16.47 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.162 -1.051 . . . . 0.44 108.162 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.585 ' HA ' HD12 ' A' ' 49' ' ' LEU . 2.7 p30 -139.57 17.04 2.54 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.389 -0.819 . . . . 1.55 109.734 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -144.37 145.28 31.86 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.227 -1.397 . . . . 1.97 107.227 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.72 HG11 ' CE2' ' A' ' 149' ' ' PHE . 7.7 p -139.35 141.79 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.451 -0.9 . . . . 0.28999999999999998 109.906 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.596 ' HG3' HG22 ' A' ' 46' ' ' VAL . 6.5 tttt -110.44 109.75 20.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.766 -0.584 . . . . 1.27 109.613 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.694 ' CD1' HG13 ' A' ' 70' ' ' VAL . 50.1 mm -100.73 120.53 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.353 -0.61 . . . . 0.29999999999999999 109.353 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.676 HG22 ' HB3' ' A' ' 44' ' ' SER . 40.1 t -126.2 114.59 39.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 O-C-N 121.225 -0.922 . . . . 0.31 109.655 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.428 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 50.7 t -89.38 147.67 23.93 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.622 -0.881 . . . . 1.1000000000000001 108.622 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.712 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -142.59 133.72 25.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.684 -0.635 . . . . 0.33000000000000002 110.967 -178.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.826 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 2.7 tp-100 149.7 128.33 0.0 OUTLIER Pre-proline 0 N--CA 1.515 2.796 0 N-CA-C 108.006 -1.109 . . . . 2.5299999999999998 108.006 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -85.1 95.94 0.65 Allowed 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 123.012 2.474 . . . . 0.81999999999999995 109.286 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.452 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 5.7 p90 -124.67 -14.2 6.83 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.47 -0.768 . . . . 0.96999999999999997 111.793 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.03 -173.54 2.33 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.109 -0.994 . . . . 1.72 110.211 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.1 tttm -170.66 -40.47 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.247 -0.649 . . . . 3.0099999999999998 109.247 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -111.0 -40.34 4.52 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.593 0.711 . . . . 1.77 109.47 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.5 OUTLIER -103.39 145.87 31.41 Favored Pre-proline 0 C--N 1.298 -1.663 0 N-CA-C 109.325 -0.621 . . . . 0.98999999999999999 109.325 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 43.7 Cg_endo -87.04 163.42 8.73 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 123.21 2.606 . . . . 0.81999999999999995 110.813 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.407 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.5 OUTLIER -167.76 -165.9 0.69 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.206 -1.035 . . . . 3.0499999999999998 108.206 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.93 -108.94 0.38 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.56 -1.305 . . . . 0.40000000000000002 110.927 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.549 HD23 HG23 ' A' ' 60' ' ' ILE . 6.3 mp -116.31 153.03 32.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.641 -0.917 . . . . 1.5600000000000001 110.759 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.431 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 7.3 m -84.44 -28.11 27.09 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.951 -0.759 . . . . 0.88 108.951 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.502 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 44.3 p90 -178.25 165.98 1.88 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.433 -0.792 . . . . 0.40999999999999998 109.045 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.813 HG22 ' HB3' ' A' ' 24' ' ' LEU . 21.3 m -141.99 137.59 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.892 -0.781 . . . . 0.5 108.892 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.422 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 4.9 mtm180 -144.84 163.9 32.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.706 -0.621 . . . . 2.21 109.952 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.72 ' CE2' HG11 ' A' ' 128' ' ' VAL . 57.4 m-85 -142.45 154.61 44.7 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.594 -0.891 . . . . 0.35999999999999999 108.594 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.446 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -155.62 131.53 9.95 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.25 -0.907 . . . . 1.24 109.794 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.052 -0.721 . . . . 1.3899999999999999 109.052 -179.933 . . . . . . . . 0 0 . 1 stop_ save_